232 results
8-K
EX-99.2
MYGN
Myriad Genetics, Inc.
3 Jun 24
In the Court of Chancery of the State of Delaware
4:06pm
shall not be offered or admitted in evidence or referred to, interpreted, construed, invoked, or otherwise used by any person for any purpose … , as amended from time to time (the “Charter”). I. Purpose The purpose of the Committee is to ensure that (A) the Company timely, accurately and comprehensively
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
3 Jun 24
In the Court of Chancery of the State of Delaware
4:06pm
, OR THE ATTORNEY’S FEE AWARD AMOUNT DESCRIBED HEREIN, NO ACTION IS REQUIRED BY YOU IN RESPONSE TO THIS NOTICE.
1.WHY ARE YOU RECEIVING THIS NOTICE?
The purpose
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
. Laboratories in the United States that perform testing on human specimens for the purpose of providing information for the diagnosis, prevention … the safety and efficacy of the IVD for its intended purpose. If the device is determined to present a “significant risk,” the sponsor may not begin a clinical
8-K
EX-1.1
uacvrs0
13 Nov 23
Entry into a Material Definitive Agreement
4:31pm
424B5
dfzy5n8agn1i6ax7q
13 Nov 23
Prospectus supplement for primary offering
6:02am
424B5
bhz1w7 zr53gw5n6y
8 Nov 23
Prospectus supplement for primary offering
4:05pm
S-3ASR
6yn a8643
8 Nov 23
Automatic shelf registration
4:01pm
S-3ASR
EX-4.3
9878es
8 Nov 23
Automatic shelf registration
4:01pm
8-K
EX-10.1
koew8b2
31 Oct 23
Entry into a Material Definitive Agreement
4:34pm
8-K
EX-10.1
k9zzky
5 Oct 23
Departure of Directors or Certain Officers
8:30am